<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Arthroplasty</journal-id><journal-id journal-id-type="iso-abbrev">Arthroplasty</journal-id><journal-id journal-id-type="pmc-domain-id">4152</journal-id><journal-id journal-id-type="pmc-domain">arthroplasty</journal-id><journal-title-group><journal-title>Arthroplasty</journal-title></journal-title-group><issn pub-type="epub">2524-7948</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11445950</article-id><article-id pub-id-type="pmcid-ver">PMC11445950.1</article-id><article-id pub-id-type="pmcaid">11445950</article-id><article-id pub-id-type="pmcaiid">11445950</article-id><article-id pub-id-type="pmid">39354637</article-id><article-id pub-id-type="doi">10.1186/s42836-024-00273-z</article-id><article-id pub-id-type="publisher-id">273</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Osteoporosis in the setting of knee arthroplasty: a narrative review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9256-9952</contrib-id><name name-style="western"><surname>Daher</surname><given-names initials="M">Mohammad</given-names></name><address><email>mohdaher1@hotmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mekhael</surname><given-names initials="E">Elio</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>El-Othmani</surname><given-names initials="MM">Mouhanad M.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04w1m5n60</institution-id><institution-id institution-id-type="GRID">grid.413559.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0571 2680</institution-id><institution>Orthopedic Department, </institution><institution>H&#244;tel Dieu de France, </institution></institution-wrap>Beirut, Lebanon </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gq02987</institution-id><institution-id institution-id-type="GRID">grid.40263.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9094</institution-id><institution>Department of Orthopedic Surgery, </institution><institution>Brown University Medical Center, </institution></institution-wrap>Providence, RI 02906 USA </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>6</volume><issue-id pub-id-type="pmc-issue-id">452489</issue-id><elocation-id>50</elocation-id><history><date date-type="received"><day>22</day><month>5</month><year>2024</year></date><date date-type="accepted"><day>2</day><month>8</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>02</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-03 10:25:45.133"><day>03</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="42836_2024_Article_273.pdf"/><abstract id="Abs1"><p id="Par1">Patients undergoing knee replacement, which is mainly indicated in severe osteoarthritis, are frequently co-affected by osteoporosis and osteopenia. With a prevalence standing at around 20% in patients receiving knee arthroplasty, osteoporosis could lead to poor outcomes postoperatively. Some of these complications include periprosthetic fractures and an increased revision rate. Antiresorptive medications have been shown to be beneficial postoperatively. However, no studies have been conducted on whether they had any benefits if given preoperatively. Surgical management may also be beneficial, but this area remains full of controversy.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Osteoporosis</kwd><kwd>Knee arthroplasty</kwd><kwd>Osteoarthritis</kwd><kwd>Knee replacement</kwd><kwd>Bone mineral density</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Arthroplasty Society in Asia 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Osteoporosis is a relatively common degenerative bone disorder with an estimated prevalence of 18.3% across the globe [<xref ref-type="bibr" rid="CR1">1</xref>]. Within the United States, 10 million Americans older than 50&#160;years suffer from osteoporosis, with an estimated additional 34 million at risk of developing the disease [<xref ref-type="bibr" rid="CR2">2</xref>]. The disease process affects bone quantity and constitutes a spectrum that is characterized by a progressive decrease in bone mineral density (BMD). This imbalance results in an increased risk of fragility fractures, which constitute a substantial morbidity and mortality risk among the frail geriatric population [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par3">Osteoarthritis is a frequently concomitant disease affecting geriatric patients. The worldwide prevalence of osteoarthritis has increased by 113.25% between 1990 and 2019, with the knee joint being cited as the most affected site [<xref ref-type="bibr" rid="CR5">5</xref>&#8211;<xref ref-type="bibr" rid="CR7">7</xref>]. As a result, the annual rate of total knee arthroplasty (TKA) is continuously increasing in the world and the US, with 4.7 million Americans receiving TKA in 2010 [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par4">In patients undergoing primary TKA, osteoporosis can pose substantial technical challenges and has been noted to be associated with a higher risk of postoperative complications and revisions [<xref ref-type="bibr" rid="CR9">9</xref>]. As such, the prevalence and severity of osteoporosis carry considerable implications for patients undergoing TKA. Thus, the purpose of this manuscript was to provide a critical appraisal of the literature and explore the prevalence of osteoporosis and osteopenia among patients undergoing TKA, describe postoperative outcomes, and highlight the available evidence on potential perioperative medical and surgical interventions to optimize outcomes and reduce any potential associated risks.</p></sec><sec id="Sec2"><title>Data collection</title><p id="Par5">PubMed was searched until December 2023 for the qualified papers. Using Boolean Operators, a combination of the keywords &#8220;knee arthroplasty&#8221; OR &#8220;knee replacement&#8221; AND &#8220;osteoporosis&#8221; OR &#8220;Osteopenia&#8221; OR &#8220;Bone mineral density&#8221; OR &#8220;BMD&#8221; was used. Reference lists from papers and online searches were also used to find literature.</p></sec><sec id="Sec3"><title>Incidence and screening</title><p id="Par6">With an aging population and continually increasing functional demand, the number of performed and projected TKA continues to grow, and the number of patients with osteopenia or osteoporosis undergoing the procedure is expected to follow suit. Studies have shown that a large number of TKA candidates were diagnosed with osteoporosis (17.4%) and osteopenia (45.9%) [<xref ref-type="bibr" rid="CR10">10</xref>] with prevalence reaching 60% in postmenopausal women awaiting TKA [<xref ref-type="bibr" rid="CR11">11</xref>]. In a recent study, Ishi et al. reported that among TKA recipients, the prevalence of dual-energy X-ray absorptiometry (DXA) defined osteoporosis was 22% in women and 5% in men [<xref ref-type="bibr" rid="CR12">12</xref>]. Moreover, in a recent meta-analysis, Xiao et al. noted that 64% of total joint arthroplasty patients suffered from osteopenia and osteoporosis [<xref ref-type="bibr" rid="CR13">13</xref>]. Interestingly, the authors reported a notably lower treatment rate at 32.9% in those with a confirmed diagnosis[<xref ref-type="bibr" rid="CR13">13</xref>]. Similarly, Ha et al. noted a prevalence of osteoporosis of 50% among patients scheduled for TKA, of which only 15.1% had pharmacological treatment prior to the procedure [<xref ref-type="bibr" rid="CR14">14</xref>]. The percentage of patients with osteoporosis receiving treatment prior to arthroplasty has been reported as low as 5% in other studies [<xref ref-type="bibr" rid="CR15">15</xref>].</p><p id="Par7">While several screening tools for identifying osteoporosis and osteopenia have been described, determining which patients benefit from presurgical DXA remains challenging. As a simple screening tool, investigating the history of &#8220;disease-defining&#8221; fractures, such as distal radius fractures, vertebral compression fractures, and hip fractures could be incorporated into the assessment of TKA candidates, and could alert clinicians for underlying and undiagnosed osteoporosis. Dual-energy computed tomography (DECT) could provide an alternative and has been shown to be an accurate estimator of BMD, whose findings correlates with the results provided by central DXA [<xref ref-type="bibr" rid="CR16">16</xref>]. The importance of preoperative DXA in the identification of orthopedic surgical patients at risk of osteoporosis has been proven in several joints such as the hip, shoulder, spine, and specifically the knee. The authors of a retrospective cohort study proposed a simple screening protocol defining who should obtain DXA due to high osteoporosis risk which included: females&#8201;&#8805;&#8201;65, males&#8201;&#8805;&#8201;70, fracture history when&#8201;&#8805;&#8201;50&#160;years, or FRAX major osteoporotic fracture risk (without bone mineral density [BMD]-adjustments)&#8201;&#8805;&#8201;8.4%. For patients receiving DXA, screening sensitivity levels reached 96% for identifying T-score osteoporosis (T-score&#8201;&#8804;&#8201;&#8201;&#8722;2.5 as defined by the WHO) and 99% for identifying modified clinical osteoporosis (T-score&#8201;&#8804;&#8201;&#8201;&#8722;2.5, BMD-adjusted FRAX risk or prior hip/spine fracture) with only 1 osteoporosis patient not meeting screening criteria recommending DXA [<xref ref-type="bibr" rid="CR17">17</xref>]. This being said, DXA remains the gold standard for the diagnosis of osteoporosis, with a T score&#8201;&#8804;&#8201;&#8201;&#8722;2.5 defining osteoporosis, and a T score between&#8201;&#8722;1 and&#8201;&#8722;2.5 defining osteopenia [<xref ref-type="bibr" rid="CR17">17</xref>]. More recently, CT scans of the knee with machine learning models have reportedly been capable of detecting up to 91.2% of the cases [<xref ref-type="bibr" rid="CR18">18</xref>].</p></sec><sec id="Sec4"><title>Impact on outcomes</title><p id="Par8">Numerous studies evaluated the impact of reduced BMD on the perioperative outcomes following TKA. In a recent study, Chang et al. noted significantly higher rates of complications and revisions following TKA among patients with osteoporosis, even after controlling for patient demographics [<xref ref-type="bibr" rid="CR19">19</xref>]. Osteoporosis or osteopenia predisposes a patient to a higher risk of perioperative complications such as fracture, implant migration, and aseptic loosening [<xref ref-type="bibr" rid="CR15">15</xref>]. Kang et al. [<xref ref-type="bibr" rid="CR20">20</xref>] reported that reduced bone density correlated with the risk of intraoperative distal femur fractures. The authors noted a BMD cutoff value of&#8201;&#8722;2.8 significantly increased the risk for intraoperative fractures by 2.3 folds (<italic toggle="yes">P</italic>&#8201;=&#8201;0.042). However, one must note that, in their surgeries, the authors did put the femoral component first in their TKA which they showed to be a risk factor for intraoperative distal femur fractures [<xref ref-type="bibr" rid="CR20">20</xref>]. Furthermore, Harris et al. noted that osteoporosis was associated with a 2-fold increased risk of 5-year revision for periprosthetic fractures after TKA [<xref ref-type="bibr" rid="CR9">9</xref>]. In addition, Holzer et al. [<xref ref-type="bibr" rid="CR21">21</xref>] exhibited a significant association between the fracture risk assessment tool (FRAX) and the incidence of suffering from periprosthetic fractures in both total hip and knee arthroplasty. Even in navigation-assisted TKA, osteoporosis was found to affect tibial component position (<italic toggle="yes">P</italic>&#8201;=&#8201;0.039), rendering osteoporotic knees in more valgus [<xref ref-type="bibr" rid="CR22">22</xref>]. This was explained by the higher likelihood of undetected intraoperative pin motion in these affected knees, which subsequently impacts the accuracy of planned bone cuts and component positioning [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par9">Other studies evaluated the effect of prior fragility fractures on the perioperative outcomes of TKA. Fragility fractures can be the initial clinical manifestation in a lot of patients. Agarwal et al. [<xref ref-type="bibr" rid="CR23">23</xref>] reported an increase in risk by 2-fold (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) for periprosthetic fractures and 3-fold (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) for future fragility fractures 8&#160;years postoperatively in patients with a fragility fracture within 3&#160;years prior to TKA. In addition to these risks, and at 2-year follow-up, Albright et al. [<xref ref-type="bibr" rid="CR24">24</xref>] noted an increased incidence of hospital readmissions (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001), non-infection-related revision surgery (<italic toggle="yes">P</italic>&#8201;=&#8201;0.002), prosthesis dislocations (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001), and deep periprosthetic infections (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001) in patients with a fragility fracture within 3&#160;years prior to TKA. Interestingly, the authors noted a lack of statistical significance of the increased revision rate (3.0% in the control group vs. 3.1% in the group with a prior fragility fracture; <italic toggle="yes">P</italic>&#8201;=&#8201;0.215), which was attributed to appropriate surgeon decision-making [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p id="Par10">Nevertheless, other studies reported the absence of a negative impact of osteoporosis on the outcomes after TKA. Huang et al. [<xref ref-type="bibr" rid="CR25">25</xref>] showed that lower bone density was associated with reduced postoperative pain and improved subjective ratings of functional outcomes. However, the study included 43 patients with a follow-up duration of six months, constituting a small cohort with a short duration that might be not long enough to accurately predict long-term results [<xref ref-type="bibr" rid="CR25">25</xref>]. Similarly, Watanabe et al. evaluated the prognosis of TKA patients and found that knee function ratings and the severity of osteoporosis did not correlate with outcomes, concluding that the latter does not adversely affect TKA results [<xref ref-type="bibr" rid="CR26">26</xref>]. On the other hand, other studies highlighted the increased risk of tibial component migration in cementless TKA in patients with lower BMD [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. However, in the latter, local BMD was found to be affected by local osteoarthritis [<xref ref-type="bibr" rid="CR29">29</xref>] and was less reflective of the patient&#8217;s general bone health status when compared to systemic BMD [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p></sec><sec id="Sec5"><title>Management</title><sec id="Sec6"><title>Medical management</title><p id="Par11">The majority of studies assessing the medical management of osteoporosis and osteopenia analyzed the effect of postoperative drugs and supplements on local periprosthetic bone health instead of whole-body BMD. Vitamin D supplementation is among the most widely studied interventions in the setting of low BMD conditions. Barker et al. [<xref ref-type="bibr" rid="CR32">32</xref>] administrated a multivitamin containing 900&#160;IU of vitamin D postoperatively to patients undergoing TKA and noted a significantly decreased postoperative inflammatory response. However, this finding might be limited by the effect of other concomitantly administered vitamins. Furthermore, another study compared 800 to 2000 IU of vitamin D postoperatively and found no difference in the rate of postoperative falls or the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) [<xref ref-type="bibr" rid="CR33">33</xref>]. Nevertheless, as the authors did not include a control group with a placebo instead of a lower dose of vitamin D, the effectiveness of the latter cannot be studied (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Studies exploring the use of medical therapy in osteoporotic patients undergoing total knee arthroplasty (BMD&#8201;=&#8201;Bone Mineral Density)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Drug</th><th align="left" colspan="1" rowspan="1">Author</th><th align="left" colspan="1" rowspan="1">Year</th><th align="left" colspan="1" rowspan="1">Results</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Vitamin D</td><td align="left" colspan="1" rowspan="1">Barker et al. </td><td align="left" colspan="1" rowspan="1">2021</td><td align="left" colspan="1" rowspan="1">Multivitamin supplement containing 900&#160;IU of vitamin D significantly decreased postoperative inflammatory response.</td></tr><tr><td align="left" colspan="1" rowspan="1">Bischoff-Ferrari et al. </td><td align="left" colspan="1" rowspan="1">2018</td><td align="left" colspan="1" rowspan="1">No difference was found in the rate of postoperative falls or WOMAC index when comparing postoperative 800 to 2000 IU of vitamin D.</td></tr><tr><td align="left" colspan="1" rowspan="1">Bisphosphonate containing cement</td><td align="left" colspan="1" rowspan="1">Mastuszewska et al. </td><td align="left" colspan="1" rowspan="1">2022</td><td align="left" colspan="1" rowspan="1">Increased levels of osteoprotegerin and decreased RANKL and therefore decreased bone resorption</td></tr><tr><td align="left" rowspan="5" colspan="1">Alendronate</td><td align="left" colspan="1" rowspan="1">Wang et al. </td><td align="left" colspan="1" rowspan="1">2003</td><td align="left" colspan="1" rowspan="1">Reduced BMD loss at the distal femur and proximal tibia</td></tr><tr><td align="left" colspan="1" rowspan="1">Soininvaara et al. </td><td align="left" colspan="1" rowspan="1">2002</td><td align="left" colspan="1" rowspan="1">Alendronate reduced early BMD loss at the metaphyseal anterior, posterior, diaphyseal, and metaphyseal regions of the femur.</td></tr><tr><td align="left" colspan="1" rowspan="1">Wang et al. </td><td align="left" colspan="1" rowspan="1">2006</td><td align="left" colspan="1" rowspan="1"><p>A six-month course of alendronate increased BMD at 6 (4.8%) and 12 (1.6%) months.</p><p>No significant difference was noted after 36&#160;months when compared to controls (&#8722;3.9% vs.&#8201;&#8722;12.2%, respectively; <italic toggle="yes">P</italic>&#8201;=&#8201;0.08).</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Jaroma et al. </td><td align="left" colspan="1" rowspan="1">2015</td><td align="left" colspan="1" rowspan="1"><p>Lateral tibial metaphysis was increased with Alendronate until seven years (<italic toggle="yes">P</italic>&#8201;=&#8201;0.002), and was significantly higher than that observed in the control group throughout (<italic toggle="yes">P</italic>&#8201;=&#8201;0.024).</p><p>No significant differences were found between the groups in the central femoral metaphyseal, tibial medial metaphyseal, or diaphyseal regions of either the femur or tibia.</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Teng et al. </td><td align="left" colspan="1" rowspan="1">2015</td><td align="left" colspan="1" rowspan="1">Long-term use of bisphosphonates was correlated with a significantly decreased risk of implant revision after total knee arthroplasty (TKA)</td></tr><tr><td align="left" rowspan="2" colspan="1">Denosumab</td><td align="left" colspan="1" rowspan="1">Murahashi et al. </td><td align="left" colspan="1" rowspan="1">2019</td><td align="left" colspan="1" rowspan="1">Improvement in BMD decreased at around 3&#160;months postoperatively compared to 6&#160;months with bisphosphonates and reduced tibial bone atrophy 12&#160;months postoperatively</td></tr><tr><td align="left" colspan="1" rowspan="1">Ledin et al. </td><td align="left" colspan="1" rowspan="1">2019</td><td align="left" colspan="1" rowspan="1">Denosumab reduced early migration of the tibial component.</td></tr><tr><td align="left" rowspan="2" colspan="1">Teriparatide</td><td align="left" colspan="1" rowspan="1">Suzuki et al. </td><td align="left" colspan="1" rowspan="1">2018</td><td align="left" colspan="1" rowspan="1">Increased periprosthetic BMD in the posterior and lateral regions of the condyles at 6&#160;months and in the anterior and posterior regions of the condyles and the tibial diaphysis at 12&#160;months</td></tr><tr><td align="left" colspan="1" rowspan="1">Kaneko et al. </td><td align="left" colspan="1" rowspan="1">2016</td><td align="left" colspan="1" rowspan="1">Weekly injection of teriparatide after cementless TKA promoted bone ingrowth mostly in the medial aspect of the bone-prosthesis interface.</td></tr></tbody></table></table-wrap></p><p id="Par12">With regards to anti-osteoporotic drugs, a study assessing bisphosphonates-containing-cement in TKA showed an increase in the level of osteoprotegerin and a decreased receptor activator of nuclear factor kappaB ligand (RANKL), thus acting on important molecular elements to decrease bone resorption [<xref ref-type="bibr" rid="CR34">34</xref>]. While these findings highlight interesting results at the cellular level, the clinical implications are yet to be determined. At a clinical level, the efficacy of a postoperative treatment with a specific bisphosphonate for a duration of 6&#160;months, alendronate was shown to reduce the BMD loss at the distal femur and proximal tibia [<xref ref-type="bibr" rid="CR35">35</xref>]. This postoperative improvement in BMD decline using alendronate was reported by multiple studies [<xref ref-type="bibr" rid="CR36">36</xref>&#8211;<xref ref-type="bibr" rid="CR39">39</xref>]. Interestingly, Murahashi et al. assessed the impact of postoperative treatment with denosumab, another anti-resorptive medication, on BMD following TKA. The authors noted an improvement in BMD decrease at around 3&#160;months postoperatively compared to 6&#160;months with bisphosphonates, and a reduced tibial bone atrophy 12&#160;months postoperatively. [<xref ref-type="bibr" rid="CR40">40</xref>]. Another study by Ledin et al. [<xref ref-type="bibr" rid="CR41">41</xref>] assessing the impact of denosumab showed a reduced early migration of the tibial component. Nevertheless, one must be cautious when using this particular drug since its discontinuation without an alternative anti-resorptive drug can cause rebound-associated vertebral fractures, with a reported increased rate from 1.2 to 7.1 per 100 participant-years [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref>]. Another anti-osteoporotic agent that can be added to the perioperative therapeutic arsenal is teriparatide, an anabolic agent. In fact, as compared to other osteoporosis drugs, this anabolic drug increases periprosthetic BMD instead of attenuating its decline, providing an effective and attractive intervention among this population [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Furthermore, in a case&#8211;control study looking at risk factors for periprosthetic fractures, Park et al. showed that a history of osteoporosis medication reduced this risk [<xref ref-type="bibr" rid="CR48">48</xref>]. No recommendations could be made yet as this is an area that needs to be much more intensively studied due to the lack of scientific articles assessing the medical management of osteoporosis in osteoporotic patients undergoing TKA.</p></sec><sec id="Sec7"><title>Surgical considerations</title><p id="Par13">With regards to surgical management, intraoperative technique, and implant selection can affect perioperative osteopenia/osteoporosis and bone tissue remodeling. In a recent meta-analysis, Prince et al. reported that average BMD loss following TKA evolved as follows: 9.3%, 13.2%, 15.8%, and 15.4% at 3, 6, 12 and 24&#160;months, respectively. The authors stress the rapid BMD decrease in the first 6&#160;months after surgery and is then sustained to 24&#160;months, highlighting the effect of bone health on the incidence of periprosthetic fracture [<xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par14">The choice of implant fixation strategy in this population is critical and remains controversial. A study showed that, in the medial and anterior region below the tibial components, BMD was shown to be decreased for cemented components by 8.6% and 4.2%, respectively, until 24-month follow-up. On the other hand, cementless components were associated with an increased BMD of 1.8% and 7.4%, respectively, until the 24-month follow-up [<xref ref-type="bibr" rid="CR50">50</xref>]. However, one must note that they excluded osteoporotic patients from their study. Moreover, a cemented mobile-bearing component was shown to prevent BMD loss after TKA whereas when the fixed-bearing component was adopted, BMD of the femur decreased. This difference was found to be statistically significant at 18 and 24&#160;months (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05), proving that a cemented mobile-bearing component could have a beneficial effect on the BMD of the femur after TKA [<xref ref-type="bibr" rid="CR51">51</xref>]. However, Ueyama et al. demonstrated, in their prospective cohort study, that there was no difference in peri-prosthetic BMD changes between mobile- and fixed-bearing prostheses in patients undergoing oral bisphosphonate therapy. This study suggested that the effect of oral bisphosphonate therapy might offset the influence of prosthetic design [<xref ref-type="bibr" rid="CR52">52</xref>]. In addition, when comparing periprosthetic BMD in patients across all ages, osteoporotic and non-osteoporotic, managed with uncemented trabecular metal and cemented tibial components, Minoda et al. showed that the postoperative decrease in BMD in the lateral aspect of the tibia was significantly less in knees with trabecular metal components than in knees with cemented tibial components at twenty-four months (6.7%&#8201;&#177;&#8201;22.9% vs. &#8211;36.8%&#8201;&#177;&#8201;24.2%; <italic toggle="yes">P</italic>&#8201;=&#8201;0.002) [<xref ref-type="bibr" rid="CR53">53</xref>]. Petersen et al. found that hydroxyapatite coating of the tibial component did not exert any significant effect on the bone remodeling pattern of the proximal tibia [<xref ref-type="bibr" rid="CR54">54</xref>]. The authors also showed that, in patients who underwent uncemented porous-coated TKA, BMD increased by 22% proximal to the fixation pegs [<xref ref-type="bibr" rid="CR55">55</xref>]. Nevertheless, one must note that while cementless fixation was associated with a lower revision rate in men, it showed a higher rate of revision in women&#8201;&gt;&#8201;65&#160;years of age[<xref ref-type="bibr" rid="CR56">56</xref>]. Furthermore, in a national database study, Dubin et al. revealed that there was a higher risk of periprosthetic fractures at 5&#160;years after TKA in osteoporotic patients undergoing cementless fixation when compared to cemented fixation [<xref ref-type="bibr" rid="CR57">57</xref>] (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Studies exploring surgical measures in osteoporotic patients undergoing total knee arthroplasty (BMD&#8201;=&#8201;Bone Mineral Density)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Author</th><th align="left" colspan="1" rowspan="1">Year</th><th align="left" colspan="1" rowspan="1">Results</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">Cemented vs. cementless components</td><td align="left" colspan="1" rowspan="1">Linde et al.</td><td align="left" colspan="1" rowspan="1">2022</td><td align="left" colspan="1" rowspan="1"><p>BMD was decreased for cemented components by 8.6% and 4.2% in the medial and anterior regions, respectively, until 24-month follow-up.</p><p>BMD was increased for cementless components by 1.8% and 7.4% in the medial and anterior regions, respectively, until 24-month follow-up.</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Dubin et al.</td><td align="left" colspan="1" rowspan="1">2024</td><td align="left" colspan="1" rowspan="1">The cementless cohort had a 5-year periprosthetic fracture risk following TKA of 7.8% (95% CI, 5.56 to 10.98) in comparison to 4.30% in the cemented cohort (85% CI, 3.98 to 4.65) (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.0001).</td></tr><tr><td align="left" colspan="1" rowspan="1">Ryan et al.</td><td align="left" colspan="1" rowspan="1">2024</td><td align="left" colspan="1" rowspan="1">Cementless fixation was associated with a lower revision rate in men, and it showed a higher rate of revision in women&#8201;&gt;&#8201;65&#160;years of age</td></tr><tr><td align="left" rowspan="2" colspan="1">Mobile- vs. fixed-bearing components</td><td align="left" colspan="1" rowspan="1">Minoda et al.</td><td align="left" colspan="1" rowspan="1">2010</td><td align="left" colspan="1" rowspan="1">Prevention of BMD loss after TKA with mobile-bearing component compared to significant BMD loss of the femur with fixed-bearing component</td></tr><tr><td align="left" colspan="1" rowspan="1">Ueyama et al.</td><td align="left" colspan="1" rowspan="1">2020</td><td align="left" colspan="1" rowspan="1"><p>No difference was found in peri-prosthetic BMD changes between mobile- and fixed-bearing prostheses in patients undergoing oral bisphosphonate therapy.</p><p>The BMD changes results are likely affected by oral bisphosphonate therapy.</p></td></tr><tr><td align="left" colspan="1" rowspan="1">Uncemented trabecular metal vs. cemented tibial components</td><td align="left" colspan="1" rowspan="1">Minoda et al.</td><td align="left" colspan="1" rowspan="1">2010</td><td align="left" colspan="1" rowspan="1">Less decrease in BMD in the lateral aspect of the tibia with trabecular metal components (6.7%&#8201;&#177;&#8201;22.9% vs &#8722;36.8%&#8201;&#177;&#8201;24.2%; <italic toggle="yes">p</italic>&#8201;=&#8201;0.002).</td></tr><tr><td align="left" colspan="1" rowspan="1">Hydroxyapatite coating of tibial component</td><td align="left" colspan="1" rowspan="1">Petersen et al.</td><td align="left" colspan="1" rowspan="1">2005</td><td align="left" colspan="1" rowspan="1">No significant effect was found on bone remodeling pattern of the proximal tibia.</td></tr><tr><td align="left" colspan="1" rowspan="1">Uncemented porous-coated component</td><td align="left" colspan="1" rowspan="1">Petersen et al.</td><td align="left" colspan="1" rowspan="1">1995</td><td align="left" colspan="1" rowspan="1">Increased BMD by 22% proximal to the fixation pegs</td></tr><tr><td align="left" colspan="1" rowspan="1">PCL retention</td><td align="left" colspan="1" rowspan="1">Ishii et al.</td><td align="left" colspan="1" rowspan="1">2017</td><td align="left" colspan="1" rowspan="1">No substantial effect was found on the BMD of the proximal femur and tibia.</td></tr><tr><td align="left" colspan="1" rowspan="1">Medial peg position</td><td align="left" colspan="1" rowspan="1">Minoda et al.</td><td align="left" colspan="1" rowspan="1">2022</td><td align="left" colspan="1" rowspan="1">The closer the tibial medial peg was to the cortex, the larger the BMD loss in the medial part of the tibia at 2&#160;years postoperatively.</td></tr><tr><td align="left" colspan="1" rowspan="1">Porous titanium construct Regenerex and porous coated (PPS) tibial tray</td><td align="left" colspan="1" rowspan="1">Winther et al.</td><td align="left" colspan="1" rowspan="1">2016</td><td align="left" colspan="1" rowspan="1">Both groups maintained peri-prosthetic BMD in lateral, medial and distal aspects below the central stem regions, with up to 8.1% and 6.5% increase at 12&#160;months for the PPS and Regenerex, respectively.</td></tr></tbody></table></table-wrap></p><p id="Par15">As for the prosthesis design, Ishii et al. showed that, when measured approximately 10&#160;years after TKA, PCL retention had no substantial effect on the BMD of the proximal femur and tibia [<xref ref-type="bibr" rid="CR58">58</xref>]. Furthermore, Minoda et al. reported that BMD decreased in the medial region after the operation (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001), which was affected by the medial peg position. The closer the tibial medial peg was to the cortex the larger the BMD loss in the medial part of the tibia at 2&#160;years postoperatively [<xref ref-type="bibr" rid="CR59">59</xref>]. Moreover, a prospective study including 60 patients scheduled for TKA suggested that both the novel porous titanium construct Regenerex and the well-proven standard porous coated (PPS) tibial tray have a favorable effect in maintaining periprosthetic BMD in lateral, medial, and distal aspects below the central stem regions, with up to 8.1% and 6.5% increase at 12&#160;months for the PPS and Regenerex, respectively [<xref ref-type="bibr" rid="CR60">60</xref>].</p></sec></sec><sec id="Sec8"><title>Conclusion</title><p id="Par16">For some candidates undergoing TKA whose characteristics need to be further defined by future studies, preoperative screening may be advised to determine which patients can benefit from a perioperative intervention. To lessen the hazards related to individuals undergoing TKA with a low BMD, medical management of the latter could be implemented. Currently, the data show that cemented fixation is favored in osteoporotic patients to reduce postoperative periprosthetic fractures. Nevertheless, more studies addressing the effectiveness of preoperative treatment with anti-osteoporotic medication as well as intraoperative surgical modifications in preventing the adverse outcomes of TKA in osteoporotic patients are needed.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>None</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>M.D.: Writing and Data collection; E.M.: Writing and Data collection; M.M.E-O.: Review and Supervision. All authors have read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>None.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Not available.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par17">Not required.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par18">Not required.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par19">None.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salari</surname><given-names>N</given-names></name><name name-style="western"><surname>Ghasemi</surname><given-names>H</given-names></name><name name-style="western"><surname>Mohammadi</surname><given-names>L</given-names></name><name name-style="western"><surname>Behzadi</surname><given-names>MH</given-names></name><name name-style="western"><surname>Rabieenia</surname><given-names>E</given-names></name><name name-style="western"><surname>Shohaimi</surname><given-names>S</given-names></name><name name-style="western"><surname>Mohammadi</surname><given-names>M</given-names></name></person-group><article-title>The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis</article-title><source>J Orthop Surg Res.</source><year>2021</year><volume>16</volume><fpage>609</fpage><pub-id pub-id-type="doi">10.1186/s13018-021-02772-0</pub-id><pub-id pub-id-type="pmid">34657598</pub-id><pub-id pub-id-type="pmcid">PMC8522202</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S, Mohammadi M. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16:609. 10.1186/s13018-021-02772-0.<pub-id pub-id-type="pmid">34657598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13018-021-02772-0</pub-id><pub-id pub-id-type="pmcid">PMC8522202</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">(US) O of the SG: Bone Health and Osteoporosis. US Heal Hum Serv. 2004, 437.</mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanis</surname><given-names>JA</given-names></name></person-group><article-title>Diagnosis of osteoporosis and assessment of fracture risk</article-title><source>Lancet</source><year>2002</year><volume>359</volume><fpage>1929</fpage><lpage>1936</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(02)08761-5</pub-id><pub-id pub-id-type="pmid">12057569</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929&#8211;36. 10.1016/S0140-6736(02)08761-5.<pub-id pub-id-type="pmid">12057569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(02)08761-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Aspray TJ, Hill TR. Osteoporosis and the ageing skeleton. 2019. 453&#8211;76.10.1007/978-981-13-3681-2_16.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-981-13-3681-2_16</pub-id><pub-id pub-id-type="pmid">30888662</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yin</surname><given-names>H</given-names></name><etal/></person-group><article-title>Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019</article-title><source>Arthritis Rheumatol</source><year>2022</year><volume>74</volume><fpage>1172</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1002/art.42089</pub-id><pub-id pub-id-type="pmid">35233975</pub-id><pub-id pub-id-type="pmcid">PMC9543105</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Long H, Liu Q, Yin H, et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022;74:1172&#8211;83. 10.1002/art.42089.<pub-id pub-id-type="pmid">35233975</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/art.42089</pub-id><pub-id pub-id-type="pmcid">PMC9543105</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vos</surname><given-names>T</given-names></name><name name-style="western"><surname>Lim</surname><given-names>SS</given-names></name><name name-style="western"><surname>Abbafati</surname><given-names>C</given-names></name><etal/></person-group><article-title>Global burden of 369 diseases and injuries in 204 countries and territories, 1990&#8211;2019: a systematic analysis for the Global Burden of Disease Study 2019</article-title><source>Lancet</source><year>2020</year><volume>396</volume><fpage>1204</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30925-9</pub-id><pub-id pub-id-type="pmid">33069326</pub-id><pub-id pub-id-type="pmcid">PMC7567026</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990&#8211;2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204&#8211;22. 10.1016/S0140-6736(20)30925-9.<pub-id pub-id-type="pmid">33069326</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30925-9</pub-id><pub-id pub-id-type="pmcid">PMC7567026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunter</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Bierma-Zeinstra</surname><given-names>S</given-names></name></person-group><article-title>Osteoarthritis</article-title><source>Lancet</source><year>2019</year><volume>393</volume><fpage>1745</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(19)30417-9</pub-id><pub-id pub-id-type="pmid">31034380</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393:1745&#8211;59. 10.1016/S0140-6736(19)30417-9.<pub-id pub-id-type="pmid">31034380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(19)30417-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maradit Kremers</surname><given-names>H</given-names></name><name name-style="western"><surname>Larson</surname><given-names>DR</given-names></name><name name-style="western"><surname>Crowson</surname><given-names>CS</given-names></name><etal/></person-group><article-title>Prevalence of total hip and knee replacement in the United States</article-title><source>J Bone Jt Surgery-American</source><year>2015</year><volume>97</volume><fpage>1386</fpage><lpage>1397</lpage><pub-id pub-id-type="doi">10.2106/JBJS.N.01141</pub-id><pub-id pub-id-type="pmcid">PMC4551172</pub-id><pub-id pub-id-type="pmid">26333733</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Maradit Kremers H, Larson DR, Crowson CS, et al. Prevalence of total hip and knee replacement in the United States. J Bone Jt Surgery-American. 2015;97:1386&#8211;97. 10.2106/JBJS.N.01141.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.N.01141</pub-id><pub-id pub-id-type="pmcid">PMC4551172</pub-id><pub-id pub-id-type="pmid">26333733</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>AB</given-names></name><name name-style="western"><surname>Lantieri</surname><given-names>MA</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>AR</given-names></name><name name-style="western"><surname>Golladay</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Thakkar</surname><given-names>SC</given-names></name></person-group><article-title>Osteoporosis and total knee arthroplasty: higher 5-year implant-related complications</article-title><source>J Arthroplasty</source><year>2024</year><volume>39</volume><fpage>948</fpage><lpage>953.e1</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2023.10.045</pub-id><pub-id pub-id-type="pmid">37914037</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Harris AB, Lantieri MA, Agarwal AR, Golladay GJ, Thakkar SC. Osteoporosis and total knee arthroplasty: higher 5-year implant-related complications. J Arthroplasty. 2024;39:948&#8211;953.e1. 10.1016/j.arth.2023.10.045.<pub-id pub-id-type="pmid">37914037</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2023.10.045</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delsmann</surname><given-names>MM</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>C</given-names></name><name name-style="western"><surname>M&#252;hlenfeld</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prevalence of osteoporosis and osteopenia in elderly patients scheduled for total knee arthroplasty</article-title><source>Arch Orthop Trauma Surg</source><year>2021</year><volume>142</volume><fpage>3957</fpage><lpage>3964</lpage><pub-id pub-id-type="doi">10.1007/s00402-021-04297-x</pub-id><pub-id pub-id-type="pmid">34919186</pub-id><pub-id pub-id-type="pmcid">PMC9596583</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Delsmann MM, Schmidt C, M&#252;hlenfeld M, et al. Prevalence of osteoporosis and osteopenia in elderly patients scheduled for total knee arthroplasty. Arch Orthop Trauma Surg. 2021;142:3957&#8211;64. 10.1007/s00402-021-04297-x.<pub-id pub-id-type="pmid">34919186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00402-021-04297-x</pub-id><pub-id pub-id-type="pmcid">PMC9596583</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tang</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>Prevalence and risk factors of osteoporosis in chinese postmenopausal women awaiting total knee arthroplasty</article-title><source>Clin Interv Aging</source><year>2021</year><volume>16</volume><fpage>379</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.2147/CIA.S297947</pub-id><pub-id pub-id-type="pmid">33664569</pub-id><pub-id pub-id-type="pmcid">PMC7924246</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Tao Y, Tang S, Huang X, Wang H, Zhou A, Zhang J. Prevalence and risk factors of osteoporosis in chinese postmenopausal women awaiting total knee arthroplasty. Clin Interv Aging. 2021;16:379&#8211;87. 10.2147/CIA.S297947.<pub-id pub-id-type="pmid">33664569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/CIA.S297947</pub-id><pub-id pub-id-type="pmcid">PMC7924246</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishii</surname><given-names>Y</given-names></name><name name-style="western"><surname>Noguchi</surname><given-names>H</given-names></name><name name-style="western"><surname>Sato</surname><given-names>J</given-names></name><etal/></person-group><article-title>Preoperative bone assessment by bone mineral density and bone turnover in patients undergoing total knee arthroplasty</article-title><source>J Orthop</source><year>2021</year><volume>28</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.jor.2021.11.011</pub-id><pub-id pub-id-type="pmid">34924727</pub-id><pub-id pub-id-type="pmcid">PMC8649577</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Ishii Y, Noguchi H, Sato J, et al. Preoperative bone assessment by bone mineral density and bone turnover in patients undergoing total knee arthroplasty. J Orthop. 2021;28:121&#8211;5. 10.1016/j.jor.2021.11.011.<pub-id pub-id-type="pmid">34924727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jor.2021.11.011</pub-id><pub-id pub-id-type="pmcid">PMC8649577</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>PL</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ma</surname><given-names>YG</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Peng</surname><given-names>R</given-names></name><name name-style="western"><surname>Xu</surname><given-names>XH</given-names></name><name name-style="western"><surname>Lu</surname><given-names>HD</given-names></name></person-group><article-title>Prevalence and treatment rate of osteoporosis in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis</article-title><source>Arch Osteoporos</source><year>2022</year><volume>17</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1007/s11657-021-01055-9</pub-id><pub-id pub-id-type="pmid">35029750</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Xiao PL, Hsu CJ, Ma YG, Liu D, Peng R, Xu XH, Lu HD. Prevalence and treatment rate of osteoporosis in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis. Arch Osteoporos. 2022;17:16. 10.1007/s11657-021-01055-9.<pub-id pub-id-type="pmid">35029750</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11657-021-01055-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ha</surname><given-names>C-W</given-names></name><name name-style="western"><surname>Park</surname><given-names>Y-B</given-names></name></person-group><article-title>Underestimation and undertreatment of osteoporosis in patients awaiting primary total knee arthroplasty</article-title><source>Arch Orthop Trauma Surg</source><year>2020</year><volume>140</volume><fpage>1109</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1007/s00402-020-03462-y</pub-id><pub-id pub-id-type="pmid">32358659</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ha C-W, Park Y-B. Underestimation and undertreatment of osteoporosis in patients awaiting primary total knee arthroplasty. Arch Orthop Trauma Surg. 2020;140:1109&#8211;14. 10.1007/s00402-020-03462-y.<pub-id pub-id-type="pmid">32358659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00402-020-03462-y</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernatz</surname><given-names>JT</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>AE</given-names></name><name name-style="western"><surname>Squire</surname><given-names>MW</given-names></name><name name-style="western"><surname>Illgen</surname><given-names>RI</given-names></name><name name-style="western"><surname>Binkley</surname><given-names>NC</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>PA</given-names></name></person-group><article-title>Osteoporosis is common and undertreated prior to total joint arthroplasty</article-title><source>J Arthroplasty</source><year>2019</year><volume>34</volume><fpage>1347</fpage><lpage>1353</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2019.03.044</pub-id><pub-id pub-id-type="pmid">30992237</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Bernatz JT, Brooks AE, Squire MW, Illgen RI, Binkley NC, Anderson PA. Osteoporosis is common and undertreated prior to total joint arthroplasty. J Arthroplasty. 2019;34:1347&#8211;53. 10.1016/j.arth.2019.03.044.<pub-id pub-id-type="pmid">30992237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2019.03.044</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Choi KY, Lee SW, In Y, et al. Dual-energy CT-based bone mineral density has practical value for osteoporosis screening around the knee. Medicina (Kaunas). 2022;58.10.3390/medicina58081085.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/medicina58081085</pub-id><pub-id pub-id-type="pmcid">PMC9416743</pub-id><pub-id pub-id-type="pmid">36013552</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>E</given-names></name><name name-style="western"><surname>Nickel</surname><given-names>B</given-names></name><name name-style="western"><surname>Binkley</surname><given-names>N</given-names></name><name name-style="western"><surname>Bernatz</surname><given-names>J</given-names></name><name name-style="western"><surname>Krueger</surname><given-names>D</given-names></name><name name-style="western"><surname>Winzenried</surname><given-names>A</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>PA</given-names></name></person-group><article-title>A novel osteoporosis screening protocol to identify orthopedic surgery patients for preoperative bone health optimization</article-title><source>Geriatr Orthop Surg Rehabil</source><year>2022</year><volume>13</volume><fpage>21514593221116412</fpage><pub-id pub-id-type="doi">10.1177/21514593221116413</pub-id><pub-id pub-id-type="pmcid">PMC9364193</pub-id><pub-id pub-id-type="pmid">35967749</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Chang E, Nickel B, Binkley N, Bernatz J, Krueger D, Winzenried A, Anderson PA. A novel osteoporosis screening protocol to identify orthopedic surgery patients for preoperative bone health optimization. Geriatr Orthop Surg Rehabil. 2022;13:21514593221116412. 10.1177/21514593221116413.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/21514593221116413</pub-id><pub-id pub-id-type="pmcid">PMC9364193</pub-id><pub-id pub-id-type="pmid">35967749</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Sebro R, Elmahdy M. Machine learning for opportunistic screening for osteoporosis and osteopenia using knee CT scans. Can Assoc Radiol J. 2023;084653712311647. 10.1177/08465371231164743.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/08465371231164743</pub-id><pub-id pub-id-type="pmid">36960893</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Chee A, &#199;eliker P, Basedow K, et al. A call to &#8220;own the bone&#8221;: osteoporosis is a predictor for adverse two-year outcomes following total hip and knee arthroplasty. Eur J Orthop Surg Traumatol. Published Online First: 2023. 10.1007/s00590-023-03499-w.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00590-023-03499-w</pub-id><pub-id pub-id-type="pmid">36894707</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Kang KH, Kim MS, Kim JJ, In Y. Risk factors and preventive strategies for perioperative distal femoral fracture in patients undergoing total knee arthroplasty. Med. 2023;59. 10.3390/medicina59020369.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/medicina59020369</pub-id><pub-id pub-id-type="pmcid">PMC9965432</pub-id><pub-id pub-id-type="pmid">36837570</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holzer</surname><given-names>LA</given-names></name><name name-style="western"><surname>Borotschnig</surname><given-names>L</given-names></name><name name-style="western"><surname>Holzer</surname><given-names>G</given-names></name></person-group><article-title>Evaluation of FRAX in patients with periprosthetic fractures following primary total hip and knee arthroplasty</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/s41598-023-34230-8</pub-id><pub-id pub-id-type="pmid">37130875</pub-id><pub-id pub-id-type="pmcid">PMC10154289</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Holzer LA, Borotschnig L, Holzer G. Evaluation of FRAX in patients with periprosthetic fractures following primary total hip and knee arthroplasty. Sci Rep. 2023;13:1&#8211;6. 10.1038/s41598-023-34230-8.<pub-id pub-id-type="pmid">37130875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-34230-8</pub-id><pub-id pub-id-type="pmcid">PMC10154289</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>DH</given-names></name><name name-style="western"><surname>Padhy</surname><given-names>D</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Nha</surname><given-names>KW</given-names></name><name name-style="western"><surname>Park</surname><given-names>JH</given-names></name><name name-style="western"><surname>Han</surname><given-names>SB</given-names></name></person-group><article-title>Osteoporosis affects component positioning in computer navigation-assisted total knee arthroplasty</article-title><source>Knee</source><year>2012</year><volume>19</volume><fpage>203</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.knee.2011.02.010</pub-id><pub-id pub-id-type="pmid">21530271</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Lee DH, Padhy D, Lee SH, Nha KW, Park JH, Han SB. Osteoporosis affects component positioning in computer navigation-assisted total knee arthroplasty. Knee. 2012;19:203&#8211;7. 10.1016/j.knee.2011.02.010.<pub-id pub-id-type="pmid">21530271</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.knee.2011.02.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Agarwal AR, Cohen JS, Tarawneh OH, Gu A, Debritz J, Golladay GJ, Thakkar SC: The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty. Osteoporos Int. Published Online First: 2023. 10.1007/s00198-023-06746-2.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00198-023-06746-2</pub-id><pub-id pub-id-type="pmid">37166492</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Albright</surname><given-names>JA</given-names></name><name name-style="western"><surname>Testa</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Meghani</surname><given-names>O</given-names></name><name name-style="western"><surname>Chang</surname><given-names>K</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>AH</given-names></name><name name-style="western"><surname>Barrett</surname><given-names>TJ</given-names></name></person-group><article-title>Increased risk of hospital readmissions and implant-related complications in patients who had a recent history of fragility fracture: a matched cohort analysis</article-title><source>J Arthroplasty</source><year>2023</year><volume>38</volume><fpage>266</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2022.08.036</pub-id><pub-id pub-id-type="pmid">36055439</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Albright JA, Testa EJ, Meghani O, Chang K, Daniels AH, Barrett TJ. Increased risk of hospital readmissions and implant-related complications in patients who had a recent history of fragility fracture: a matched cohort analysis. J Arthroplasty. 2023;38:266&#8211;73. 10.1016/j.arth.2022.08.036.<pub-id pub-id-type="pmid">36055439</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2022.08.036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>CH</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>H</given-names></name></person-group><article-title>Local bone quality affects the outcome of prosthetic total knee arthroplasty</article-title><source>J Orthop Res</source><year>2016</year><volume>34</volume><fpage>240</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1002/jor.23003</pub-id><pub-id pub-id-type="pmid">26222735</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Huang CC, Jiang CC, Hsieh CH, Tsai CJ, Chiang H. Local bone quality affects the outcome of prosthetic total knee arthroplasty. J Orthop Res. 2016;34:240&#8211;8. 10.1002/jor.23003.<pub-id pub-id-type="pmid">26222735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jor.23003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Watanabe Y, Yamamoto S, Isawa K, Yamada N, Hirota Y. Functional prognosis of total knee arthroplasty in osteoporotic elderly patients. Orthop Proc. 2019;101-B.</mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>MR</given-names></name><name name-style="western"><surname>Winther</surname><given-names>NS</given-names></name><name name-style="western"><surname>Lind</surname><given-names>T</given-names></name><name name-style="western"><surname>Schr&#248;der</surname><given-names>HM</given-names></name><name name-style="western"><surname>Flivik</surname><given-names>G</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>MM</given-names></name></person-group><article-title>Low Preoperative BMD is related to high migration of tibia components in uncemented TKA-92 patients in a combined DEXA and RSA study with 2-year follow-up</article-title><source>J Arthroplasty</source><year>2017</year><volume>32</volume><fpage>2141</fpage><lpage>2146</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2017.02.032</pub-id><pub-id pub-id-type="pmid">28410836</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Andersen MR, Winther NS, Lind T, Schr&#248;der HM, Flivik G, Petersen MM. Low Preoperative BMD is related to high migration of tibia components in uncemented TKA-92 patients in a combined DEXA and RSA study with 2-year follow-up. J Arthroplasty. 2017;32:2141&#8211;6. 10.1016/j.arth.2017.02.032.<pub-id pub-id-type="pmid">28410836</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2017.02.032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petersen</surname><given-names>MM</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>PT</given-names></name><name name-style="western"><surname>Lebech</surname><given-names>A</given-names></name><name name-style="western"><surname>Toksvig-Larsen</surname><given-names>S</given-names></name><name name-style="western"><surname>Lund</surname><given-names>B</given-names></name></person-group><article-title>Preoperative bone mineral density of the proximal tibia and migration of the tibial component after uncemented total knee arthroplasty</article-title><source>J Arthroplasty</source><year>1999</year><volume>14</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/s0883-5403(99)90206-1</pub-id><pub-id pub-id-type="pmid">9926957</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Petersen MM, Nielsen PT, Lebech A, Toksvig-Larsen S, Lund B. Preoperative bone mineral density of the proximal tibia and migration of the tibial component after uncemented total knee arthroplasty. J Arthroplasty. 1999;14:77&#8211;81. 10.1016/s0883-5403(99)90206-1.<pub-id pub-id-type="pmid">9926957</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0883-5403(99)90206-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#228;kinen</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Alm</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Laine</surname><given-names>H</given-names></name><name name-style="western"><surname>Svedstr&#246;m</surname><given-names>E</given-names></name><name name-style="western"><surname>Aro</surname><given-names>HT</given-names></name></person-group><article-title>The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement</article-title><source>Bone</source><year>2007</year><volume>40</volume><fpage>1041</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2006.11.013</pub-id><pub-id pub-id-type="pmid">17239668</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">M&#228;kinen TJ, Alm JJ, Laine H, Svedstr&#246;m E, Aro HT. The incidence of osteopenia and osteoporosis in women with hip osteoarthritis scheduled for cementless total joint replacement. Bone. 2007;40:1041&#8211;7. 10.1016/j.bone.2006.11.013.<pub-id pub-id-type="pmid">17239668</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bone.2006.11.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lingard</surname><given-names>EA</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>SY</given-names></name><name name-style="western"><surname>Francis</surname><given-names>RM</given-names></name><name name-style="western"><surname>Rawlings</surname><given-names>D</given-names></name><name name-style="western"><surname>Peaston</surname><given-names>R</given-names></name><name name-style="western"><surname>Birrell</surname><given-names>FN</given-names></name><name name-style="western"><surname>McCaskie</surname><given-names>AW</given-names></name></person-group><article-title>The prevalence of osteoporosis in patients with severe hip and knee osteoarthritis awaiting joint arthroplasty</article-title><source>Age Ageing</source><year>2010</year><volume>39</volume><fpage>234</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1093/ageing/afp222</pub-id><pub-id pub-id-type="pmid">20032523</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Lingard EA, Mitchell SY, Francis RM, Rawlings D, Peaston R, Birrell FN, McCaskie AW. The prevalence of osteoporosis in patients with severe hip and knee osteoarthritis awaiting joint arthroplasty. Age Ageing. 2010;39:234&#8211;9. 10.1093/ageing/afp222.<pub-id pub-id-type="pmid">20032523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ageing/afp222</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linde</surname><given-names>KN</given-names></name><name name-style="western"><surname>Puhakka</surname><given-names>KB</given-names></name><name name-style="western"><surname>Langdahl</surname><given-names>BL</given-names></name><name name-style="western"><surname>S&#248;balle</surname><given-names>K</given-names></name><name name-style="western"><surname>Krog-Mikkelsen</surname><given-names>I</given-names></name><name name-style="western"><surname>Madsen</surname><given-names>F</given-names></name><name name-style="western"><surname>Stilling</surname><given-names>M</given-names></name></person-group><article-title>Bone mineral density is lower in patients with severe knee osteoarthritis and attrition</article-title><source>Calcif Tissue Int</source><year>2017</year><volume>101</volume><fpage>593</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1007/s00223-017-0315-y</pub-id><pub-id pub-id-type="pmid">28840578</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Linde KN, Puhakka KB, Langdahl BL, S&#248;balle K, Krog-Mikkelsen I, Madsen F, Stilling M. Bone mineral density is lower in patients with severe knee osteoarthritis and attrition. Calcif Tissue Int. 2017;101:593&#8211;601. 10.1007/s00223-017-0315-y.<pub-id pub-id-type="pmid">28840578</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00223-017-0315-y</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barker</surname><given-names>T</given-names></name><name name-style="western"><surname>Henriksen</surname><given-names>VT</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>VE</given-names></name><name name-style="western"><surname>Trawick</surname><given-names>RH</given-names></name><name name-style="western"><surname>Momberger</surname><given-names>NG</given-names></name><name name-style="western"><surname>Lynn Rasmussen</surname><given-names>G</given-names></name></person-group><article-title>Multi-vitamin supplementation blunts the circulating IL-6/IL-10 ratio increase after knee arthroplasty: a randomized, double-blind, placebo controlled study</article-title><source>Cytokine</source><year>2021</year><volume>140</volume><fpage>155435</fpage><pub-id pub-id-type="doi">10.1016/j.cyto.2021.155435</pub-id><pub-id pub-id-type="pmid">33497870</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Barker T, Henriksen VT, Rogers VE, Trawick RH, Momberger NG, Lynn Rasmussen G. Multi-vitamin supplementation blunts the circulating IL-6/IL-10 ratio increase after knee arthroplasty: a randomized, double-blind, placebo controlled study. Cytokine. 2021;140:155435. 10.1016/j.cyto.2021.155435.<pub-id pub-id-type="pmid">33497870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cyto.2021.155435</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bischoff-Ferrari</surname><given-names>HA</given-names></name><name name-style="western"><surname>Orav</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Egli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Recovery after unilateral knee replacement due to severe osteoarthritis and progression in the contralateral knee: a randomised clinical trial comparing daily 2000 IU versus 800 IU vitamin D</article-title><source>RMD Open</source><year>2018</year><volume>4</volume><fpage>e000678</fpage><pub-id pub-id-type="doi">10.1136/rmdopen-2018-000678</pub-id><pub-id pub-id-type="pmid">30018805</pub-id><pub-id pub-id-type="pmcid">PMC6045766</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Bischoff-Ferrari HA, Orav EJ, Egli A, et al. Recovery after unilateral knee replacement due to severe osteoarthritis and progression in the contralateral knee: a randomised clinical trial comparing daily 2000 IU versus 800 IU vitamin D. RMD Open. 2018;4:e000678. 10.1136/rmdopen-2018-000678.<pub-id pub-id-type="pmid">30018805</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/rmdopen-2018-000678</pub-id><pub-id pub-id-type="pmcid">PMC6045766</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matuszewska</surname><given-names>A</given-names></name><name name-style="western"><surname>Matuszewski</surname><given-names>&#321;</given-names></name><name name-style="western"><surname>Jaszek</surname><given-names>M</given-names></name><name name-style="western"><surname>Polak</surname><given-names>P</given-names></name><name name-style="western"><surname>Stec</surname><given-names>S</given-names></name></person-group><article-title>Effect of bisphosphonates on selected markers of bone turnover in patients after total knee arthroplasty</article-title><source>Int Orthop</source><year>2022</year><volume>46</volume><fpage>1529</fpage><lpage>1538</lpage><pub-id pub-id-type="doi">10.1007/s00264-022-05407-z</pub-id><pub-id pub-id-type="pmid">35482061</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Matuszewska A, Matuszewski &#321;, Jaszek M, Polak P, Stec S. Effect of bisphosphonates on selected markers of bone turnover in patients after total knee arthroplasty. Int Orthop. 2022;46:1529&#8211;38. 10.1007/s00264-022-05407-z.<pub-id pub-id-type="pmid">35482061</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00264-022-05407-z</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JW</given-names></name><name name-style="western"><surname>Weng</surname><given-names>LH</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>CC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HS</given-names></name></person-group><article-title>The effect of Alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty</article-title><source>J Bone Jt Surg</source><year>2003</year><volume>85</volume><fpage>2121</fpage><lpage>2126</lpage><pub-id pub-id-type="doi">10.2106/00004623-200311000-00009</pub-id><pub-id pub-id-type="pmid">14630840</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Chen HS. The effect of Alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty. J Bone Jt Surg. 2003;85:2121&#8211;6. 10.2106/00004623-200311000-00009.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/00004623-200311000-00009</pub-id><pub-id pub-id-type="pmid">14630840</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soininvaara</surname><given-names>TA</given-names></name><name name-style="western"><surname>Jurvelin</surname><given-names>JS</given-names></name><name name-style="western"><surname>Miettinen</surname><given-names>HJA</given-names></name><name name-style="western"><surname>Suomalainen</surname><given-names>OT</given-names></name><name name-style="western"><surname>Alhava</surname><given-names>EM</given-names></name><name name-style="western"><surname>Kr&#246;ger</surname><given-names>PJ</given-names></name></person-group><article-title>Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients</article-title><source>Calcif Tissue Int</source><year>2002</year><volume>71</volume><fpage>472</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1007/s00223-002-1022-9</pub-id><pub-id pub-id-type="pmid">12370800</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Soininvaara TA, Jurvelin JS, Miettinen HJA, Suomalainen OT, Alhava EM, Kr&#246;ger PJ. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients. Calcif Tissue Int. 2002;71:472&#8211;7. 10.1007/s00223-002-1022-9.<pub-id pub-id-type="pmid">12370800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00223-002-1022-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JW</given-names></name><name name-style="western"><surname>Ko</surname><given-names>JY</given-names></name><name name-style="western"><surname>Weng</surname><given-names>LH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CC</given-names></name></person-group><article-title>Three-year changes in bone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty. A prospective, randomized study</article-title><source>J Bone Joint Surg Am.</source><year>2006</year><volume>88</volume><fpage>267</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.2106/JBJS.E.00051</pub-id><pub-id pub-id-type="pmid">16452736</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Wang CJ, Wang JW, Ko JY, Weng LH, Huang CC. Three-year changes in bone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty. A prospective, randomized study. J Bone Joint Surg Am. 2006;88:267&#8211;72. 10.2106/JBJS.E.00051.<pub-id pub-id-type="pmid">16452736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.E.00051</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaroma</surname><given-names>AVJ</given-names></name><name name-style="western"><surname>Soininvaara</surname><given-names>TA</given-names></name><name name-style="western"><surname>Kr&#246;ger</surname><given-names>H</given-names></name></person-group><article-title>Effect of one-year post-operative alendronate treatment on periprosthetic bone after total knee arthroplasty. A seven-year randomised controlled trial of 26 patients</article-title><source>Bone Joint J.</source><year>2015</year><volume>97-B</volume><fpage>337</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.97B3.33643</pub-id><pub-id pub-id-type="pmid">25737517</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Jaroma AVJ, Soininvaara TA, Kr&#246;ger H. Effect of one-year post-operative alendronate treatment on periprosthetic bone after total knee arthroplasty. A seven-year randomised controlled trial of 26 patients. Bone Joint J. 2015;97-B:337&#8211;45. 10.1302/0301-620X.97B3.33643.<pub-id pub-id-type="pmid">25737517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/0301-620X.97B3.33643</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teng</surname><given-names>S</given-names></name><name name-style="western"><surname>Yi</surname><given-names>C</given-names></name><name name-style="western"><surname>Krettek</surname><given-names>C</given-names></name><name name-style="western"><surname>Jagodzinski</surname><given-names>M</given-names></name></person-group><article-title>Bisphosphonate use and risk of implant revision after total hip/knee arthroplasty: a meta-analysis of observational studies</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0139927</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0139927</pub-id><pub-id pub-id-type="pmid">26444555</pub-id><pub-id pub-id-type="pmcid">PMC4596810</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Teng S, Yi C, Krettek C, Jagodzinski M. Bisphosphonate use and risk of implant revision after total hip/knee arthroplasty: a meta-analysis of observational studies. PLoS ONE. 2015;10:e0139927. 10.1371/journal.pone.0139927.<pub-id pub-id-type="pmid">26444555</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0139927</pub-id><pub-id pub-id-type="pmcid">PMC4596810</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murahashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Teramoto</surname><given-names>A</given-names></name><name name-style="western"><surname>Jimbo</surname><given-names>S</given-names></name><etal/></person-group><article-title>Denosumab prevents periprosthetic bone mineral density loss in the tibial metaphysis in total knee arthroplasty</article-title><source>Knee</source><year>2020</year><volume>27</volume><fpage>580</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.knee.2019.12.010</pub-id><pub-id pub-id-type="pmid">31928902</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Murahashi Y, Teramoto A, Jimbo S, et al. Denosumab prevents periprosthetic bone mineral density loss in the tibial metaphysis in total knee arthroplasty. Knee. 2020;27:580&#8211;6. 10.1016/j.knee.2019.12.010.<pub-id pub-id-type="pmid">31928902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.knee.2019.12.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ledin</surname><given-names>H</given-names></name><name name-style="western"><surname>Good</surname><given-names>L</given-names></name><name name-style="western"><surname>Aspenberg</surname><given-names>P</given-names></name></person-group><article-title>Denosumab reduces early migration in total knee replacement</article-title><source>Acta Orthop</source><year>2017</year><volume>88</volume><fpage>255</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1080/17453674.2017.1300746</pub-id><pub-id pub-id-type="pmid">28287004</pub-id><pub-id pub-id-type="pmcid">PMC5434591</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Ledin H, Good L, Aspenberg P. Denosumab reduces early migration in total knee replacement. Acta Orthop. 2017;88:255&#8211;8. 10.1080/17453674.2017.1300746.<pub-id pub-id-type="pmid">28287004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/17453674.2017.1300746</pub-id><pub-id pub-id-type="pmcid">PMC5434591</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamy</surname><given-names>O</given-names></name><name name-style="western"><surname>Gonzalez-Rodriguez</surname><given-names>E</given-names></name><name name-style="western"><surname>Stoll</surname><given-names>D</given-names></name><name name-style="western"><surname>Hans</surname><given-names>D</given-names></name><name name-style="western"><surname>Aubry-Rozier</surname><given-names>B</given-names></name></person-group><article-title>Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 clinical cases report</article-title><source>J Clin Endocrinol Metab</source><year>2017</year><volume>102</volume><fpage>354</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1210/jc.2016-3170</pub-id><pub-id pub-id-type="pmid">27732330</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Lamy O, Gonzalez-Rodriguez E, Stoll D, Hans D, Aubry-Rozier B. Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 clinical cases report. J Clin Endocrinol Metab. 2017;102:354&#8211;8. 10.1210/jc.2016-3170.<pub-id pub-id-type="pmid">27732330</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/jc.2016-3170</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anastasilakis</surname><given-names>AD</given-names></name><name name-style="western"><surname>Polyzos</surname><given-names>SA</given-names></name><name name-style="western"><surname>Makras</surname><given-names>P</given-names></name><name name-style="western"><surname>Aubry-Rozier</surname><given-names>B</given-names></name><name name-style="western"><surname>Kaouri</surname><given-names>S</given-names></name><name name-style="western"><surname>Lamy</surname><given-names>O</given-names></name></person-group><article-title>Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases</article-title><source>J Bone Miner Res</source><year>2017</year><volume>32</volume><fpage>1291</fpage><lpage>1296</lpage><pub-id pub-id-type="doi">10.1002/jbmr.3110</pub-id><pub-id pub-id-type="pmid">28240371</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O. Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases. J Bone Miner Res. 2017;32:1291&#8211;6. 10.1002/jbmr.3110.<pub-id pub-id-type="pmid">28240371</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jbmr.3110</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Popp</surname><given-names>AW</given-names></name><name name-style="western"><surname>Zysset</surname><given-names>PK</given-names></name><name name-style="western"><surname>Lippuner</surname><given-names>K</given-names></name></person-group><article-title>Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics</article-title><source>Osteoporos Int</source><year>2016</year><volume>27</volume><fpage>1917</fpage><lpage>1921</lpage><pub-id pub-id-type="doi">10.1007/s00198-015-3458-6</pub-id><pub-id pub-id-type="pmid">26694598</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Popp AW, Zysset PK, Lippuner K. Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics. Osteoporos Int. 2016;27:1917&#8211;21. 10.1007/s00198-015-3458-6.<pub-id pub-id-type="pmid">26694598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00198-015-3458-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cummings</surname><given-names>SR</given-names></name><name name-style="western"><surname>Ferrari</surname><given-names>S</given-names></name><name name-style="western"><surname>Eastell</surname><given-names>R</given-names></name><etal/></person-group><article-title>vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension</article-title><source>J Bone Miner Res</source><year>2018</year><volume>33</volume><fpage>190</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1002/jbmr.3337</pub-id><pub-id pub-id-type="pmid">29105841</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Cummings SR, Ferrari S, Eastell R, et al. vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res. 2018;33:190&#8211;8. 10.1002/jbmr.3337.<pub-id pub-id-type="pmid">29105841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jbmr.3337</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Sukezaki</surname><given-names>F</given-names></name><name name-style="western"><surname>Shibuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Toyoshima</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nagai</surname><given-names>T</given-names></name><name name-style="western"><surname>Inagaki</surname><given-names>K</given-names></name></person-group><article-title>Teriparatide administration increases periprosthetic bone mineral density after total knee arthroplasty: a prospective study</article-title><source>J Arthroplasty</source><year>2018</year><volume>33</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2017.07.026</pub-id><pub-id pub-id-type="pmid">28869116</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Suzuki T, Sukezaki F, Shibuki T, Toyoshima Y, Nagai T, Inagaki K. Teriparatide administration increases periprosthetic bone mineral density after total knee arthroplasty: a prospective study. J Arthroplasty. 2018;33:79&#8211;85. 10.1016/j.arth.2017.07.026.<pub-id pub-id-type="pmid">28869116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2017.07.026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaneko</surname><given-names>T</given-names></name><name name-style="western"><surname>Otani</surname><given-names>T</given-names></name><name name-style="western"><surname>Kono</surname><given-names>N</given-names></name><etal/></person-group><article-title>Weekly injection of teriparatide for bone ingrowth after cementless total knee arthroplasty</article-title><source>J Orthop Surg (Hong Kong)</source><year>2016</year><volume>24</volume><fpage>16</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1177/230949901602400106</pub-id><pub-id pub-id-type="pmid">27122506</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Kaneko T, Otani T, Kono N, et al. Weekly injection of teriparatide for bone ingrowth after cementless total knee arthroplasty. J Orthop Surg (Hong Kong). 2016;24:16&#8211;21. 10.1177/230949901602400106.<pub-id pub-id-type="pmid">27122506</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/230949901602400106</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">Park YB, Kim M, Nam HC, Jeon JW, Ha CW. Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture. Osteoporos Int. Published Online First: 27 May 2024. 10.1007/s00198-024-07138-w.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00198-024-07138-w</pub-id><pub-id pub-id-type="pmid">38801524</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">Prince JM, Bernatz JT, Binkley N, Abdel MP, Anderson PA. Changes in femoral bone mineral density after total knee arthroplasty: a systematic review and meta-analysis. Arch Osteoporos. 2019;14. 10.1007/S11657-019-0572-7.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11657-019-0572-7</pub-id><pub-id pub-id-type="pmid">30798359</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linde</surname><given-names>KN</given-names></name><name name-style="western"><surname>Rytter</surname><given-names>S</given-names></name><name name-style="western"><surname>S&#248;balle</surname><given-names>K</given-names></name><name name-style="western"><surname>Madsen</surname><given-names>F</given-names></name><name name-style="western"><surname>Langdahl</surname><given-names>B</given-names></name><name name-style="western"><surname>Stilling</surname><given-names>M</given-names></name></person-group><article-title>Component migration, bone mineral density changes, and bone turnover markers in cementless and cemented total knee arthroplasty: a prospective randomized RSA study in 53 patients with 2-year follow-up</article-title><source>Knee Surg Sport Traumatol Arthrosc</source><year>2022</year><volume>30</volume><fpage>3100</fpage><lpage>3113</lpage><pub-id pub-id-type="doi">10.1007/S00167-022-06860-4/METRICS</pub-id><pub-id pub-id-type="pmid">35099597</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Linde KN, Rytter S, S&#248;balle K, Madsen F, Langdahl B, Stilling M. Component migration, bone mineral density changes, and bone turnover markers in cementless and cemented total knee arthroplasty: a prospective randomized RSA study in 53 patients with 2-year follow-up. Knee Surg Sport Traumatol Arthrosc. 2022;30:3100&#8211;13. 10.1007/S00167-022-06860-4/METRICS.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00167-022-06860-4</pub-id><pub-id pub-id-type="pmid">35099597</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minoda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ikebuchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>A</given-names></name><name name-style="western"><surname>Iwaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Inori</surname><given-names>F</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>H</given-names></name></person-group><article-title>A cemented mobile-bearing total knee replacement prevents periprosthetic loss of bone mineral density around the femoral component: a matched cohort study</article-title><source>J Bone Jt Surg - Ser B</source><year>2010</year><volume>92</volume><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.92B6.23159/LETTERTOEDITOR</pub-id><pub-id pub-id-type="pmid">20513875</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Minoda Y, Ikebuchi M, Kobayashi A, Iwaki H, Inori F, Nakamura H. A cemented mobile-bearing total knee replacement prevents periprosthetic loss of bone mineral density around the femoral component: a matched cohort study. J Bone Jt Surg - Ser B. 2010;92:794&#8211;8. 10.1302/0301-620X.92B6.23159/LETTERTOEDITOR.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1302/0301-620X.92B6.23159</pub-id><pub-id pub-id-type="pmid">20513875</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ueyama</surname><given-names>H</given-names></name><name name-style="western"><surname>Minoda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sugama</surname><given-names>R</given-names></name><name name-style="western"><surname>Ohta</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>S</given-names></name><name name-style="western"><surname>Takemura</surname><given-names>S</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>H</given-names></name></person-group><article-title>Peri-prosthetic bone mineral density after simultaneous bilateral total knee arthroplasty under oral bisphosphonate therapy - a comparison between mobile- and fixed-bearing prostheses</article-title><source>Knee</source><year>2020</year><volume>27</volume><fpage>767</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1016/J.KNEE.2020.04.011</pub-id><pub-id pub-id-type="pmid">32563435</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Ueyama H, Minoda Y, Sugama R, Ohta Y, Nakamura S, Takemura S, Nakamura H. Peri-prosthetic bone mineral density after simultaneous bilateral total knee arthroplasty under oral bisphosphonate therapy - a comparison between mobile- and fixed-bearing prostheses. Knee. 2020;27:767&#8211;76. 10.1016/J.KNEE.2020.04.011.<pub-id pub-id-type="pmid">32563435</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.knee.2020.04.011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minoda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>A</given-names></name><name name-style="western"><surname>Iwaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Ikebuchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Inori</surname><given-names>F</given-names></name><name name-style="western"><surname>Takaoka</surname><given-names>K</given-names></name></person-group><article-title>Comparison of bone mineral density between porous tantalum and cemented tibial total knee arthroplasty components</article-title><source>J Bone Joint Surg Am</source><year>2010</year><volume>92</volume><fpage>700</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.2106/JBJS.H.01349</pub-id><pub-id pub-id-type="pmid">20194329</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Minoda Y, Kobayashi A, Iwaki H, Ikebuchi M, Inori F, Takaoka K. Comparison of bone mineral density between porous tantalum and cemented tibial total knee arthroplasty components. J Bone Joint Surg Am. 2010;92:700&#8211;6. 10.2106/JBJS.H.01349.<pub-id pub-id-type="pmid">20194329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2106/JBJS.H.01349</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petersen</surname><given-names>MM</given-names></name><name name-style="western"><surname>Gehrchen</surname><given-names>PM</given-names></name><name name-style="western"><surname>&#216;stgaard</surname><given-names>SE</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>PK</given-names></name><name name-style="western"><surname>Lund</surname><given-names>B</given-names></name></person-group><article-title>Effect of hydroxyapatite-coated tibial components on changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty: a prospective randomized study using dual-energy x-ray absorptiometry</article-title><source>J Arthroplasty</source><year>2005</year><volume>20</volume><fpage>516</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/J.ARTH.2004.09.041</pub-id><pub-id pub-id-type="pmid">16124970</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Petersen MM, Gehrchen PM, &#216;stgaard SE, Nielsen PK, Lund B. Effect of hydroxyapatite-coated tibial components on changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty: a prospective randomized study using dual-energy x-ray absorptiometry. J Arthroplasty. 2005;20:516&#8211;20. 10.1016/J.ARTH.2004.09.041.<pub-id pub-id-type="pmid">16124970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2004.09.041</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petersen</surname><given-names>MM</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>C</given-names></name><name name-style="western"><surname>Lauritzen</surname><given-names>JB</given-names></name><name name-style="western"><surname>Lund</surname><given-names>B</given-names></name></person-group><article-title>Changes in bone mineral density of the distal femur following uncemented total knee arthroplasty</article-title><source>J Arthroplasty</source><year>1995</year><volume>10</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0883-5403(05)80094-4</pub-id><pub-id pub-id-type="pmid">7730833</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Petersen MM, Olsen C, Lauritzen JB, Lund B. Changes in bone mineral density of the distal femur following uncemented total knee arthroplasty. J Arthroplasty. 1995;10:7&#8211;11. 10.1016/S0883-5403(05)80094-4.<pub-id pub-id-type="pmid">7730833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0883-5403(05)80094-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>SP</given-names></name><name name-style="western"><surname>Stambough</surname><given-names>JB</given-names></name><name name-style="western"><surname>Huddleston</surname><given-names>JI</given-names></name><name name-style="western"><surname>Levine</surname><given-names>BR</given-names></name></person-group><article-title>Highlights of the 2023 American Joint Replacement Registry Annual Report</article-title><source>Arthroplast Today</source><year>2024</year><volume>26</volume><fpage>101325</fpage><pub-id pub-id-type="doi">10.1016/j.artd.2024.101325</pub-id><pub-id pub-id-type="pmid">39006856</pub-id><pub-id pub-id-type="pmcid">PMC11239969</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Ryan SP, Stambough JB, Huddleston JI, Levine BR. Highlights of the 2023 American Joint Replacement Registry Annual Report. Arthroplast Today. 2024;26:101325. 10.1016/j.artd.2024.101325.<pub-id pub-id-type="pmid">39006856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.artd.2024.101325</pub-id><pub-id pub-id-type="pmcid">PMC11239969</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubin</surname><given-names>JA</given-names></name><name name-style="western"><surname>Bains</surname><given-names>SS</given-names></name><name name-style="western"><surname>Monarrez</surname><given-names>R</given-names></name><etal/></person-group><article-title>The effect of fixation type on periprosthetic fractures in high-risk patients who have osteoporosis undergoing total joint arthroplasty</article-title><source>J Orthop</source><year>2024</year><volume>56</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.jor.2024.05.008</pub-id><pub-id pub-id-type="pmid">38784945</pub-id><pub-id pub-id-type="pmcid">PMC11109352</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Dubin JA, Bains SS, Monarrez R, et al. The effect of fixation type on periprosthetic fractures in high-risk patients who have osteoporosis undergoing total joint arthroplasty. J Orthop. 2024;56:26&#8211;31. 10.1016/j.jor.2024.05.008.<pub-id pub-id-type="pmid">38784945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jor.2024.05.008</pub-id><pub-id pub-id-type="pmcid">PMC11109352</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ishii</surname><given-names>Y</given-names></name><name name-style="western"><surname>Noguchi</surname><given-names>H</given-names></name><name name-style="western"><surname>Sato</surname><given-names>J</given-names></name><name name-style="western"><surname>Todoroki</surname><given-names>K</given-names></name><name name-style="western"><surname>Toyabe</surname><given-names>SI</given-names></name></person-group><article-title>Posterior cruciate ligament retention or substitution during total knee arthroplasty does not affect long-term bone mineral density or quality</article-title><source>J Arthroplasty.</source><year>2017</year><volume>32</volume><fpage>1148</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/J.ARTH.2016.10.010</pub-id><pub-id pub-id-type="pmid">27856067</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Ishii Y, Noguchi H, Sato J, Todoroki K, Toyabe SI. Posterior cruciate ligament retention or substitution during total knee arthroplasty does not affect long-term bone mineral density or quality. J Arthroplasty. 2017;32:1148&#8211;52. 10.1016/J.ARTH.2016.10.010.<pub-id pub-id-type="pmid">27856067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arth.2016.10.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minoda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ikebuchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Medial peg position of cementless porous tantalum tibial component affects bone mineral density around the prosthesis after total knee arthroplasty: 2-year follow-up study</article-title><source>Knee</source><year>2022</year><volume>34</volume><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.knee.2021.11.005</pub-id><pub-id pub-id-type="pmid">34875497</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Minoda Y, Ikebuchi M, Kobayashi A, et al. Medial peg position of cementless porous tantalum tibial component affects bone mineral density around the prosthesis after total knee arthroplasty: 2-year follow-up study. Knee. 2022;34:55&#8211;61. 10.1016/j.knee.2021.11.005.<pub-id pub-id-type="pmid">34875497</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.knee.2021.11.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winther</surname><given-names>N</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>C</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>M</given-names></name><name name-style="western"><surname>Lind</surname><given-names>T</given-names></name><name name-style="western"><surname>Schr&#248;der</surname><given-names>H</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>M</given-names></name></person-group><article-title>Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A prospective randomized study</article-title><source>Int Orthop</source><year>2016</year><volume>40</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1007/S00264-015-2852-1</pub-id><pub-id pub-id-type="pmid">26183139</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Winther N, Jensen C, Petersen M, Lind T, Schr&#248;der H, Petersen M. Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A prospective randomized study. Int Orthop. 2016;40:285&#8211;94. 10.1007/S00264-015-2852-1.<pub-id pub-id-type="pmid">26183139</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00264-015-2852-1</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>